Skip to main content
Kelly Olino, MD, General Surgery, New Haven, CT

KellyOlinoMD

General Surgery New Haven, CT

Surgical Oncology (Other than Breast)

Assistant Professor of Surgery Smilow Cancer Center Yale New Haven Hospital

Dr. Olino is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Olino's full profile

Already have an account?

  • Office

    20 York St
    Smilow Cancer Center
    New Haven, CT 06510
    Phone+1 203-737-8875

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 2013 - 2015
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Surgery, 2005 - 2013
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 2005

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2013 - 2026
  • CT State Medical License
    CT State Medical License 2018 - 2025
  • TX State Medical License
    TX State Medical License 2015 - 2019
  • MD State Medical License
    MD State Medical License 2007 - 2013
  • American Board of Surgery Surgery
  • American Board of Surgery Complex General Surgical Oncology

Awards, Honors, & Recognition

  • Texas Rising Star Super Doctors, 2018

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Prevalence of False-Negative Results of Intraoperative Consultation on Surgical Margins During Resection of Gastric and Gastroesophageal Adenocarcinoma  
    Daniel G Coit, Kelly Olino, David S Klimstra, Kambiz Kamrani, Murray F Brennan, JAMA

Press Mentions

  • Yale Study Highlights Unmet Needs for Patients with Melanoma Who Progress or Relapse After Immunotherapy Treatment
    Yale Study Highlights Unmet Needs for Patients with Melanoma Who Progress or Relapse After Immunotherapy TreatmentAugust 30th, 2024

Professional Memberships